Protagen AG employs the proprietary UNIarray® platform to support clinical studies I-IV. Our approach builds on the systematic and comprehensive autoantibody profiling of patients serum with focus on autoimmune diseases, neurodegenerative disorders, and cancer. Collaboration projects have successfully been performed with Bayer (Endometriosis), Biogen-Idec (MS), and SuppreMol (SLE).